Across TCGA pan-cancer cohorts, RPS26P5 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RPS26P5 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RPS26P5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS26P5 expression acts as an unfavorable survival marker.

KIRC and SKCM are the cancer types where RPS26P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.656	0.802	.029	36	view →
SKCM	OS	Tertile	IV	0.415	0.861	.014	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RPS26P5 tumor-vs-normal RNA expression · all RPS26P5 data types